Aurora Spine Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Aurora Spine's earnings have been declining at an average annual rate of -8%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 12.2% per year.
Información clave
-8.0%
Tasa de crecimiento de los beneficios
1.0%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | -19.2% |
| Tasa de crecimiento de los ingresos | 12.2% |
| Rentabilidad financiera | -12.7% |
| Margen neto | -3.8% |
| Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Aurora Spine Corporation (CVE:ASG) Soars 26% But It's A Story Of Risk Vs Reward
Oct 19
We Think Aurora Spine (CVE:ASG) Has A Fair Chunk Of Debt
Oct 16Aurora Spine Corporation's (CVE:ASG) Subdued P/S Might Signal An Opportunity
Aug 14We Think Shareholders May Want To Consider A Review Of Aurora Spine Corporation's (CVE:ASG) CEO Compensation Package
Jun 19Is Aurora Spine (CVE:ASG) A Risky Investment?
May 29There Is A Reason Aurora Spine Corporation's (CVE:ASG) Price Is Undemanding
Mar 19Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?
Oct 15Why Investors Shouldn't Be Surprised By Aurora Spine Corporation's (CVE:ASG) Low P/S
Aug 11Here's Why Aurora Spine (CVE:ASG) Can Afford Some Debt
May 01Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt
Dec 22Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?
Aug 23Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?
May 04Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?
Dec 23Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt
Jun 11A Look At The Intrinsic Value Of Aurora Spine Corporation (CVE:ASG)
Feb 26Is Aurora Spine (CVE:ASG) A Risky Investment?
Nov 19
Desglose de ingresos y gastos
Cómo gana y gasta dinero Aurora Spine. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 17 | -1 | 9 | 1 |
| 30 Jun 24 | 16 | -1 | 8 | 1 |
| 31 Mar 24 | 16 | -1 | 8 | 1 |
| 31 Dec 23 | 15 | -2 | 8 | 1 |
| 30 Sep 23 | 14 | -2 | 7 | 1 |
| 30 Jun 23 | 14 | -2 | 7 | 1 |
| 31 Mar 23 | 14 | -2 | 7 | 1 |
| 31 Dec 22 | 15 | -2 | 7 | 1 |
| 30 Sep 22 | 14 | -2 | 7 | 1 |
| 30 Jun 22 | 13 | -2 | 7 | 1 |
| 31 Mar 22 | 12 | -2 | 6 | 1 |
| 31 Dec 21 | 11 | -2 | 6 | 1 |
| 30 Sep 21 | 10 | -1 | 5 | 1 |
| 30 Jun 21 | 9 | -1 | 5 | 1 |
| 31 Mar 21 | 9 | 0 | 4 | 0 |
| 31 Dec 20 | 9 | 0 | 4 | 0 |
| 30 Sep 20 | 9 | -1 | 4 | 0 |
| 30 Jun 20 | 9 | -2 | 4 | 0 |
| 31 Mar 20 | 11 | -2 | 4 | 0 |
| 31 Dec 19 | 11 | -1 | 4 | 0 |
| 30 Sep 19 | 11 | -1 | 4 | 0 |
| 30 Jun 19 | 11 | 0 | 4 | 0 |
| 31 Mar 19 | 10 | 0 | 4 | 0 |
| 31 Dec 18 | 9 | 0 | 4 | 0 |
| 30 Sep 18 | 8 | -1 | 4 | 0 |
| 30 Jun 18 | 7 | -1 | 3 | 0 |
| 31 Mar 18 | 6 | -2 | 4 | 0 |
| 31 Dec 17 | 6 | -2 | 4 | 0 |
| 30 Sep 17 | 6 | -2 | 4 | 0 |
| 30 Jun 17 | 6 | -2 | 4 | 0 |
| 31 Mar 17 | 7 | -2 | 4 | 0 |
| 31 Dec 16 | 7 | -2 | 4 | 0 |
| 30 Sep 16 | 7 | -2 | 4 | 0 |
| 30 Jun 16 | 6 | -2 | 4 | 0 |
| 31 Mar 16 | 5 | -2 | 4 | 0 |
| 31 Dec 15 | 5 | -3 | 5 | 0 |
| 30 Sep 15 | 5 | -5 | 7 | 0 |
| 30 Jun 15 | 4 | -6 | 8 | 0 |
| 31 Mar 15 | 4 | -8 | 9 | 0 |
| 31 Dec 14 | 3 | -8 | 8 | 0 |
| 30 Sep 14 | 1 | -6 | 7 | 0 |
| 30 Jun 14 | 1 | -5 | 5 | 0 |
| 31 Mar 14 | 0 | -4 | 4 | 0 |
| 31 Dec 13 | 0 | -3 | 3 | 0 |
Ingresos de calidad: ASG is currently unprofitable.
Margen de beneficios creciente: ASG is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ASG is unprofitable, and losses have increased over the past 5 years at a rate of 8% per year.
Acelerando crecimiento: Unable to compare ASG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: ASG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Rentabilidad financiera
Alta ROE: ASG has a negative Return on Equity (-12.65%), as it is currently unprofitable.